Eckhardt S. Ferdinandi

720 total citations
30 papers, 484 citations indexed

About

Eckhardt S. Ferdinandi is a scholar working on Organic Chemistry, Pharmacology and Pharmacology. According to data from OpenAlex, Eckhardt S. Ferdinandi has authored 30 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Eckhardt S. Ferdinandi's work include Pharmacogenetics and Drug Metabolism (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Eckhardt S. Ferdinandi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Eckhardt S. Ferdinandi collaborates with scholars based in United States, Canada and United Kingdom. Eckhardt S. Ferdinandi's co-authors include Mitchell N. Cayen, D. Dvornik, E. Greselin, Alfred Häßner, M. Kraml, George Just, William T. Robinson, Christopher A. Demerson, J. F. Douglas and J. J. Kneiss and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eckhardt S. Ferdinandi

30 papers receiving 429 citations

Peers

Eckhardt S. Ferdinandi

PHARM

HTM

Colin F. Chignell United States

Alex Cohen United States

Itsuo Yoshizawa Japan

Anne Misher United States

Steven Cepa United States

Appavu Chandrasekaran United States

Kenneth C. Morton United States

László Institóris Hungary

H J Smith United Kingdom

Yukio Mori Japan

Colin F. Chignell United States

Eckhardt S. Ferdinandi

221 ×1.7

141 ×1.2

50 ×0.5

PHARM

103 ×1.1

PHARM

45 ×0.8

HTM

Citations per year, relative to Eckhardt S. Ferdinandi Eckhardt S. Ferdinandi (= 1×) peers Colin F. Chignell

Countries citing papers authored by Eckhardt S. Ferdinandi

Since Specialization

Citations

This map shows the geographic impact of Eckhardt S. Ferdinandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckhardt S. Ferdinandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckhardt S. Ferdinandi more than expected).

Fields of papers citing papers by Eckhardt S. Ferdinandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckhardt S. Ferdinandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckhardt S. Ferdinandi. The network helps show where Eckhardt S. Ferdinandi may publish in the future.

Co-authorship network of co-authors of Eckhardt S. Ferdinandi

This figure shows the co-authorship network connecting the top 25 collaborators of Eckhardt S. Ferdinandi. A scholar is included among the top collaborators of Eckhardt S. Ferdinandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eckhardt S. Ferdinandi. Eckhardt S. Ferdinandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferdinandi, Eckhardt S., Aikaterini Vassilakos, Yoon Lee, et al.. (2010). Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2. Cancer Chemotherapy and Pharmacology. 68(1). 193–205. 9 indexed citations

Ferdinandi, Eckhardt S., et al.. (2006). Non‐Clinical Pharmacology and Safety Evaluation of TH9507, a Human Growth Hormone‐Releasing Factor Analogue. Basic & Clinical Pharmacology & Toxicology. 100(1). 49–58. 27 indexed citations

Jansen, Mendel, Ian A. Darby, Thierry Abribat, et al.. (2004). Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog. International Journal of Pharmaceutics. 276(1-2). 75–81. 11 indexed citations

Plotzke, Kathleen P., et al.. (2000). Disposition of Radioactivity in Fischer 344 Rats after Single and Multiple Inhalation Exposure to [14C]Octamethylcyclotetrasiloxane ([14C]D4). Drug Metabolism and Disposition. 28(2). 192–204. 39 indexed citations

Liu, Chun‐Jen, et al.. (2000). Virulizin-2gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts.. International Journal of Oncology. 16(5). 1015–20. 8 indexed citations

Miller, Mary J., et al.. (1997). Pharmacokinetics and Disposition of Methyl t-Butyl Ether in Fischer-344 Rats. Journal of Applied Toxicology. 17(S1). S3–S12. 34 indexed citations

Cayen, Mitchell N., Eckhardt S. Ferdinandi, David Hicks, et al.. (1990). Pharmacokinetics and disposition of the lipid-lowering drug acifran in normal subjects and in patients with renal failure. Clinical Pharmacology & Therapeutics. 47(1). 50–56. 3 indexed citations

Humber, Leslie G., et al.. (1988). Etodolac, a novel antiinflammatory agent. The syntheses and biological evaluation of its metabolites. Journal of Medicinal Chemistry. 31(9). 1712–1719. 36 indexed citations

Ferdinandi, Eckhardt S., et al.. (1987). Identification of the etodolac metabolite, 4-ureidoetodolac, in mouse, rat, dog, and man.. Drug Metabolism and Disposition. 15(6). 921–924. 5 indexed citations

10.

Ferdinandi, Eckhardt S., et al.. (1986). Disposition and biotransformation of¹⁴C-etodolac in man. Xenobiotica. 16(2). 153–166. 26 indexed citations

11.

Cayen, Mitchell N., David Hicks, Eckhardt S. Ferdinandi, et al.. (1985). Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.. Drug Metabolism and Disposition. 13(4). 412–419. 14 indexed citations

12.

Ferdinandi, Eckhardt S., Mitchell N. Cayen, & C.R. Pace-Asciak. (1982). Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.. Journal of Pharmacology and Experimental Therapeutics. 220(2). 417–426. 16 indexed citations

13.

Cayen, Mitchell N., M. Kraml, Eckhardt S. Ferdinandi, E. Greselin, & D. Dvornik. (1981). The Metabolic Disposition of Etodolac in Rats, Dogs, and Man. Drug Metabolism Reviews. 12(2). 339–362. 49 indexed citations

14.

Cayen, Mitchell N., Eckhardt S. Ferdinandi, E. Greselin, & D. Dvornik. (1979). Studies on the disposition of diosgenin in rats, dogs, monkeys and man. Atherosclerosis. 33(1). 71–87. 39 indexed citations

15.

Ferdinandi, Eckhardt S., et al.. (1978). Synthesis of [¹⁴C]labelled pyrano[3,4‐b]‐and thiopyrano[3,4‐b]indoles, and indeno[2,1‐c]pyran derivatives. Journal of Labelled Compounds and Radiopharmaceuticals. 14(3). 411–425. 6 indexed citations

16.

Ferdinandi, Eckhardt S., et al.. (1978). Synthesis of [14‐¹⁴C] dexclamol hydrochloride and [14‐¹⁴C] butaclamol hydrochloride. Journal of Labelled Compounds and Radiopharmaceuticals. 14(5). 757–765. 1 indexed citations

17.

Cayen, Mitchell N., Eckhardt S. Ferdinandi, E. Greselin, William T. Robinson, & D. Dvornik. (1977). Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.. Journal of Pharmacology and Experimental Therapeutics. 200(1). 33–43. 44 indexed citations

18.

Bagli, Jehan F., et al.. (1976). Synthesis and antihypertensive activity of some thienylethanolamines. Journal of Medicinal Chemistry. 19(7). 876–882. 15 indexed citations

19.

Ferdinandi, Eckhardt S.. (1975). Preparation of [2‐¹⁴C]‐2‐(p‐chlorophenoxy)‐2‐methylpropionic acid and its ethyl ester, [¹⁴C] clofibrate. Journal of Labelled Compounds. 11(2). 287–289. 4 indexed citations

20.

Ferdinandi, Eckhardt S. & George Just. (1971). A Synthesis of d,l-Prostaglandin E₂ Methyl Ester and Related Compounds. Canadian Journal of Chemistry. 49(7). 1070–1084. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact